5-Hydroxymethylcytosine profiles of cfDNA are highly predictive of R-CHOP treatment response in diffuse large B cell lymphoma patients
2021 · Clinical Epigenetics · 27 citations
https://doi.org/10.1186/s13148-020-00973-8
C
Changjian Yan
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
14
Papers
56
Citations
3
h-index
3
i10-index
Changjian Yan is an academic researcher from Fujian Medical University. The author has contributed to research in topics: Acute Myeloid Leukemia Research & Lymphoma Diagnosis and Treatment & Cancer Genomics and Diagnostics. The author has an h-index of 3, co-authored 12 publications.
Papers by this author
worksAdditional file 1 of 5-Hydroxymethylcytosine profiles of cfDNA are highly predictive of R-CHOP treatment response in diffuse large B cell lymphoma patients
2021 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.13940109
Additional file 3 of 5-Hydroxymethylcytosine profiles of cfDNA are highly predictive of R-CHOP treatment response in diffuse large B cell lymphoma patients
2021 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.13940115
CD9 antibody enhances the anti-leukemia efficacy of γδT cells in adult B cell acute lymphoblastic leukemia
2025 · iScience · 0 citations
https://doi.org/10.1016/j.isci.2025.113752
Longitudinal serum metabolomics predicts therapeutic outcome in acute myeloid leukemia
2025 · Translational Oncology · 0 citations
https://doi.org/10.1016/j.tranon.2025.102567
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat